Mammary gland infection F1: Mammary infection, allergy with excessive yellow nasal mucus discharge, skin infection, appendicitis or stomach ulcer.

1. Mammary gland infection: Two reports on 143 acute mammary gland infection patients who took F1 for about a week showed 116 were cured (81.11%), 15 significantly improved (10.48%), 10 improved (6.99%) and only two did not improve (1.40%).

2. Allergy and antihistamine: Of 68 sinus infection patients who took F1 or its modification, 66 patients were cured and other two improved.

3. Skin infections: A report on 227 severe skin-infection patients who took F1 found 225 patients were cured, and only two died. The average treatment time was between 15 and 60 days. In another study using F1 with antibiotics to treat 43 patients with deep carbuncles, or abscesses, from 10 to 50 days, all 43 patients were cured. Several other reports show similar results on skin infections.

4. Digestive track ulcer: A report on 53 digestive tract ulcers patients who were treated with F1 for a month showed 35 were cured (66.04%), 15 improved (28.30%) and three did not improve. Another 88 patients were divided into a treatment group taking F1 (n=58) and a comparison group (n=30) taking regular antacid medicine. Cured: 47 vs. 20 (81.03% vs. 66.67%), significantly improved: 8 vs. 9 (13.79% vs. 30%), improved: 3 vs. 0 (5.17% vs. 0%) and not improved: 0 vs. 1 (0% vs. 3.33%). There was no difference in the total effectiveness rate, P>0.05. However, there was a very significant difference in the cure rate, P<0.01.

5. Thrombosed phlebitis: Two reports on 123 patients who took F1 and also applied F1 externally showed 86 patients were cured (69.91%), 34 improved (27.64%), and three did not improve (2.445).

6. Perirectal (anal) abscess: 156 patients were treated with F1 for three weeks and were all cured.

7. Abscess tonsillitis: 60 patients took F1 for up to a week and 57 patients were cured (95%).

Toxicity and side effects: There are no known side effects or toxicity of F1.